glp 1 agonist news Injections of an ultra-long-acting investigational GLP-1 led to significant weight loss in people with overweight or obesity, with reductions continuing after a switch to once-monthly dosing, according to the ongoing VESPER Science's 2023 Breakthrough: GLP-1 Agonists
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22



























